InterVene Revenue and Competitors

InterVene Inc. is a medical device company developing interventional technologies to treat and prevent chronic venous insufficiency (CVI) with a focus on deep veins and severe, complex venous diseases.\n \nThe company’s Recana™ thrombectomy catheter system is designed to recanalize chronically obstructed deep veins and to facilitate treatment of in-stent restenosis, particularly in cases where recanalization options are limited or long-term stent maintenance is required. Recana is an investigational device limited by Federal (US) law to investigational use.\n \nBased in Redwood City, California, InterVene has assembled an exemplary team of employees, investors, advisors and board members, all possessing extensive vascular and venous interventional market experience.